These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 32844573

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB, Yang K, Yu HY, Liu M.
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. LncRNA GAS5 modulates the progression of non-small cell lung cancer through repressing miR-221-3p and up-regulating IRF2.
    Ma J, Miao H, Zhang H, Ren J, Qu S, Da J, Xu F, Zhao H.
    Diagn Pathol; 2021 May 22; 16(1):46. PubMed ID: 34022918
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X, Zheng H.
    Thorac Cancer; 2020 Feb 22; 11(2):295-304. PubMed ID: 31788970
    [Abstract] [Full Text] [Related]

  • 9. Long noncoding RNA TUSC7 inhibits cell proliferation, migration and invasion by regulating SOCS4 (SOCS5) expression through targeting miR-616 in endometrial carcinoma.
    Wu X, Cai D, Zhang F, Li M, Wan Q.
    Life Sci; 2019 Aug 15; 231():116549. PubMed ID: 31200002
    [Abstract] [Full Text] [Related]

  • 10. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L, Chen D, Song J.
    Thorac Cancer; 2020 Mar 15; 11(3):603-611. PubMed ID: 31953899
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Knockdown SNHG20 Suppresses Nonsmall Cell Lung Cancer Development by Repressing Proliferation, Migration and Invasion, and Inducing Apoptosis by Regulating miR-2467-3p/E2F3.
    Chen H, Tan X, Ding Y.
    Cancer Biother Radiopharm; 2021 May 15; 36(4):360-370. PubMed ID: 32456448
    [Abstract] [Full Text] [Related]

  • 15. Knockdown of lncRNA HCG11 suppresses cell progression in ovarian cancer by modulating miR-144-3p/PBX3.
    Li XF, Hu DM, Zhao YX, Zhang L, Jin Y.
    Eur Rev Med Pharmacol Sci; 2020 Nov 15; 24(21):11032-11040. PubMed ID: 33215418
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long non-coding RNA HCG11 enhances osteosarcoma phenotypes by sponging miR-1245b-5p that directly inhibits plakophilin 2.
    Yan H, Zhou Y, Chen Z, Yan X, Zhu L.
    Bioengineered; 2022 Jan 15; 13(1):140-154. PubMed ID: 34949159
    [Abstract] [Full Text] [Related]

  • 18. LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1.
    Wei S, Liu J, Li X, Liu X.
    BMC Pulm Med; 2020 Mar 30; 20(1):78. PubMed ID: 32228546
    [Abstract] [Full Text] [Related]

  • 19. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
    Wei S, Wang K, Huang X, Zhao Z, Zhao Z.
    Int J Immunopathol Pharmacol; 2019 Mar 30; 33():2058738419859699. PubMed ID: 31240979
    [Abstract] [Full Text] [Related]

  • 20. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W, Zhang Y, Xia S.
    Thorac Cancer; 2020 Mar 30; 11(3):549-560. PubMed ID: 31923353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.